Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Federal Trade Commission
Dow
QuintilesIMS
Citi
McKesson
Covington
Daiichi Sankyo

Generated: May 24, 2018

DrugPatentWatch Database Preview

DEMEROL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Demerol, and when can generic versions of Demerol launch?

Demerol is a drug marketed by Hospira and Us Pharm Holdings and is included in two NDAs.

The generic ingredient in DEMEROL is meperidine hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
Drug patent expirations by year for DEMEROL
Pharmacology for DEMEROL
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for DEMEROL
Synonyms for DEMEROL
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]
1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester(Meperidine)
1-Methyl-4-phenylisonipecotic acid, ethyl ester
1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
4-Carbethoxy-1-methyl-4-phenylpiperidine
4-Ethoxycarbonyl-1-methyl-4-phenyl-piperidinium
4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
4-Piperidinecarboxylicacid,1-methyl-4-phenyl-,ethylester
50-13-5 (hydrochloride)
57-42-1
9E338QE28F
AC1L1HBJ
AKOS028114528
BDBM50026752
C07128
Centralgin (Salt/Mix)
CHEBI:6754
CHEMBL607
D00UYE
D08343
DB00454
DEA No. 9230
Demarol
Demerol (TN)
Dispadol (Salt/Mix)
DivK1c_000983
Dolantin (Salt/Mix)
Dolaren (Salt/Mix)
Dolcontral (Salt/Mix)
Dolosal (Salt/Mix)
Dolsin
Dolsin (Salt/Mix)
DR000638
DTXSID9023253
EINECS 200-329-1
Ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate
Ethyl 1-methyl-4-phenylisonipecotate
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
GTPL7221
HE354977
HSDB 3116
IDI1_000983
Isonipecain
Isonipecaine
Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester
KBio1_000983
L000908
Lidol (Salt/Mix)
LS-85121
Lydol
Lydol (Salt/Mix)
Mepergan
meperidine
Meperidine solution
Meperidine solution, 1 mg/mL in methanol, drug standard
Meperidine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Meperidol
Methyl phenylpiperidine carbonic acid ethyl ester
N-Methyl-4-phenyl-4-carbethoxypiperidine
Nemerol
NINDS_000983
Operidine (Salt/Mix)
Operidine EPJ I
Operidine EPJ-I
Petantin (Salt/Mix)
Pethanol
Pethidin
Pethidine
Pethidine (INN)
Pethidine (Meperidine) 0.1 mg/ml in Methanol
Pethidine (Meperidine) 1.0 mg/ml in Methanol
Pethidine [INN:BAN]
Pethidine DBL
Pethidine DBL (TN)
Pethidine HCl
Pethidineter
Pethidinum
Pethidinum [INN-Latin]
Petidina
Petidina [INN-Spanish]
Petydyna
Petydyna [Polish]
Phetidine
Piperosal
Pipersal
Piridosal (Salt/Mix)
Renaudin
SCHEMBL25431
SR-01000944492
SR-01000944492-1
UNII-9E338QE28F
XADCESSVHJOZHK-UHFFFAOYSA-N
YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
ZINC1681

US Patents and Regulatory Information for DEMEROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharm Holdings DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 005010-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharm Holdings DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 005010-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cerilliant
Queensland Health
QuintilesIMS
Merck
Mallinckrodt
Teva
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.